Screener
Integra LifeSciences IART Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income (expense), net | 4,186 | (1,946) | 8,665 | (2,090) |
| Income (loss) before income taxes | 4,744 | (530,952) | 2,333 | (560,988) |
| Provision (benefit) for income taxes | 262 | (46,879) | 2,467 | (51,622) |
| Net income (loss) | $4,482 | $(484,073) | $(134) | $(509,366) |
| Net income (loss) per share | ||||
| Basic | $0.06 | $(6.31) | — | $(6.65) |
| Diluted | $0.06 | $(6.31) | — | $(6.65) |
| Weighted average common shares outstanding (See Note 12): |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's net income?
- Integra LifeSciences (IART) reported net income of $4.48M in Q2 2026.
- How has Integra LifeSciences's net income changed year-over-year?
- Integra LifeSciences's net income increased by 100.9% year-over-year, from -$484.07M to $4.48M.
- What is the long-term trend for Integra LifeSciences's net income?
- Over 3 years (2021 to 2025), Integra LifeSciences's net income has grown at a 45.1% compound annual growth rate (CAGR), from $169.08M to -$516.47M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Integra LifeSciences's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude